See the DrugPatentWatch profile for Retavase
What is “Retavase mg” and what strength does it come in?
“Retavase” is a brand name for reteplase, a thrombolytic (clot-busting) medicine used for certain types of acute myocardial infarction (heart attack). A user searching “Retavase mg” is usually looking for the mg strength per vial or the dose in mg.
However, the exact mg strength and how many mg are in a vial are not provided in the information available here, so I can’t state the specific “mg” value accurately.
What dose is typically used for Retavase (reteplase) in a heart attack?
Reteplase dosing depends on the indication and the prescribing protocol for acute myocardial infarction. To give the correct mg dose, I need the exact dosing form you mean (for example: per vial strength) and the clinical context (adult MI protocol).
Are you asking about vial contents, prescription dose, or label strength?
“Retavase mg” can mean different things. If you tell me which one you need, I can give a precise answer using the right details:
- the mg per vial (strength on the package)
- the total mg per treatment course
- the dose in mg for a specific patient/setting (ER/ICU protocol)
If this is a dosing question, what details should you share?
If this is for dosing, share:
- the country (labeling can differ)
- the number of vials or what the label says (for example, “X mg” on the carton)
- whether it’s for acute MI and adult vs. pediatric use (reteplase is generally for acute MI in adults)
Send the exact text from the package (the “X mg” part) or a photo transcription, and I’ll tell you what it means and how the dosing is calculated.